Surgery – Controlled release therapeutic device or system – Osmotic or diffusion pumped device or system
Patent
1986-06-02
1987-07-21
Yasko, John D.
Surgery
Controlled release therapeutic device or system
Osmotic or diffusion pumped device or system
A61K 900
Patent
active
046815848
ABSTRACT:
A high flux transdermal nitroglycerin therapeutic system is disclosed which is capable of delivering nitroglycerin through intact human skin at rates of 40 .mu.g/cm.sup.2 hr and preferably in the range of 50-150 .mu.g/cm.sup.2 hr. Ethanol delivered at a rate of from 250-500 .mu.g/cm.sup.2 hr is employed as a permeation enhancer for the nitroglycerin and a rate controlling membrane formed from ethylene vinyl acetate having a vinyl acetate content greater than 11% and preferably between 12-18% provides the appropriate rate control for both the drug and the permeation enhancer. This system is suitable for use in treatment of angina pectoris and congestive heart failure.
REFERENCES:
patent: 4615699 (1986-10-01), Gale et al.
Berggren Randall G.
Gale Robert M.
ALZA Corporation
Mandell Edward L.
Sabatine Paul L.
Stone Steven F.
Yasko John D.
LandOfFree
Transdermal delivery system for delivering nitroglycerin at high does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transdermal delivery system for delivering nitroglycerin at high, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal delivery system for delivering nitroglycerin at high will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-205010